- Home
- VIVS vs AQB Comparison
VIVS vs AQB Comparison
Compare VIVS & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- AQB
- Stock Information
- Founded
- VIVS 2007
- AQB 1991
- Country
- VIVS United States
- AQB United States
- Employees
- VIVS N/A
- AQB N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- AQB
- Sector
- VIVS Health Care
- AQB
- Exchange
- VIVS Nasdaq
- AQB Nasdaq
- Market Cap
- VIVS 3.6M
- AQB 2.9M
- IPO Year
- VIVS N/A
- AQB N/A
- Fundamental
- Price
- VIVS $1.80
- AQB $0.82
- Analyst Decision
- VIVS
- AQB
- Analyst Count
- VIVS 0
- AQB 0
- Target Price
- VIVS N/A
- AQB N/A
- AVG Volume (30 Days)
- VIVS 137.3K
- AQB 800.7K
- Earning Date
- VIVS 06-06-2025
- AQB 05-15-2025
- Dividend Yield
- VIVS N/A
- AQB N/A
- EPS Growth
- VIVS N/A
- AQB N/A
- EPS
- VIVS N/A
- AQB N/A
- Revenue
- VIVS $122,000.00
- AQB N/A
- Revenue This Year
- VIVS $59.08
- AQB N/A
- Revenue Next Year
- VIVS $18.24
- AQB N/A
- P/E Ratio
- VIVS N/A
- AQB N/A
- Revenue Growth
- VIVS N/A
- AQB N/A
- 52 Week Low
- VIVS $1.56
- AQB $0.47
- 52 Week High
- VIVS $21.96
- AQB $1.94
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- AQB 53.29
- Support Level
- VIVS N/A
- AQB $0.81
- Resistance Level
- VIVS N/A
- AQB $0.90
- Average True Range (ATR)
- VIVS 0.00
- AQB 0.11
- MACD
- VIVS 0.00
- AQB 0.00
- Stochastic Oscillator
- VIVS 0.00
- AQB 59.49
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.